360
Views
2
CrossRef citations to date
0
Altmetric
Review

Mental health status, health service utilization, drug use behaviors associated with non-fatal overdose among people who use illicit drugs: A meta-analysis

ORCID Icon, ORCID Icon &
Pages 154-165 | Received 21 Sep 2021, Accepted 13 Dec 2021, Published online: 29 Dec 2021

References

  • Armoon, B., Noroozi, M., Jorjoran Shushtari, Z., Sharhani, A., Ahounbar, E., Karimi, S., Ahmadi, S., Farhoudian, A., Rahmani, A., & Abbasi, M. (2018). Factors associated with HIV risk perception among people who inject drugs: Findings from a cross-sectional behavioral survey in Kermanshah, Iran. Journal of Substance Use, 23(1), 63–66. https://doi.org/10.1080/14659891.2017.1348554
  • Babak, K., Mohammad, A., Mazaher, G., & Samaneh, A. (2017). Clinical and laboratory findings of rhabdomyolysis in opioid overdose patients in the intensive care unit of a poisoning center in 2014 in Iran. Epidemiology and Health, 39, e2017050. https://doi.org/10.4178/epih.e2017050
  • Bartu, A., Freeman, N. C., Gawthorne, G. S., Codde, J. P., & Holman, C. D. A. J. (2004). Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction, 99(1), 53–60. https://doi.org/10.1111/j.1360-0443.2004.00602.x
  • Bazazi, A. R., Zelenev, A., Fu, J. J., Yee, I., Kamarulzaman, A., & Altice, F. L. (2015). High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. International Journal of Drug Policy, 26(7), 675–681. https://doi.org/10.1016/j.drugpo.2014.11.010
  • Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4), 1088–1101. https://doi.org/10.2307/2533446
  • Belackova, V., Salmon, A. M., Day, C. A., Ritter, A., Shanahan, M., Hedrich, D., Kerr, T., & Jauncey, M. (2019). Drug consumption rooms: A systematic review of evaluation methodologies. Drug and Alcohol Review, 38(4), 406–422. https://doi.org/10.1111/dar.12919
  • Bergenstrom, A., Quan, V. M., Nam, L. V., Mcclausland, K., Thuoc, N. P., Celentano, D., & Go, V. (2008). A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among out-of-treatment injecting drug users in North Vietnam. Substance Use & Misuse, 43(1), 73–84. https://doi.org/10.1080/10826080701205109
  • Blackburn, N., Lancaster, K., Ha, T., Latkin, C., Miller, W., Frangakis, C., Chu, V., Sripaipan, T., Quan, V., & Minh, N. (2017). Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: A cross-sectional analysis to inform future overdose prevention programs. Harm Reduction Journal, 14(1), 1–9. https://doi.org/10.1186/s12954-017-0188-4
  • Bonar, E. E., & Bohnert, A. S. (2016). Perceived severity of and susceptibility to overdose among injection drug users: Relationships with overdose history. Substance Use & Misuse, 51(10), 1379–1383. https://doi.org/10.3109/10826084.2016.1168447
  • Brådvik, L., Frank, A., Hulenvik, P., Medvedeo, A., & Berglund, M. (2007). Heroin addicts reporting previous heroin overdoses also report suicide attempts. Suicide & Life-threatening Behavior, 37(4), 475–481. https://doi.org/10.1521/suli.2007.37.4.475
  • Britton, P. C., Wines, J. D., Jr, & Conner, K. R. (2010). Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug and Alcohol Dependence, 107(1), 51–55. https://doi.org/10.1016/j.drugalcdep.2009.09.005
  • Brugal, M. T., Barrio, G., Fuente, L. D. L., Regidor, E., Royuela, L., & Suelves, J. M. (2002). Factors associated with non‐fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction, 97(3), 319–327. https://doi.org/10.1046/j.1360-0443.2002.00058.x
  • Brugal, M. T., Domingo‐Salvany, A., Puig, R., Barrio, G., Garcia de Olalla, P., & De La Fuente, L. (2005). Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction, 100(7), 981–989. https://doi.org/10.1111/j.1360-0443.2005.01089.x
  • Burke, L. G., Zhou, X., Boyle, K. L., Orav, E. J., Bernson, D., Hood, M. E., Land, T., Bharel, M., & Frakt, A. B. (2020). Trends in opioid use disorder and overdose among opioid‐naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction, 115(3), 493–504. https://doi.org/10.1111/add.14867
  • Caplehorn, J. R., Dalton, M. S., Haldar, F., Petrenas, A.-M., & Nisbet, J. G. (1996). Methadone maintenance and addicts’ risk of fatal heroin overdose. Substance Use & Misuse, 31(2), 177–196. https://doi.org/10.3109/10826089609045806
  • Chahua, M., Sordo, L., Barrio, G., Domingo-Salvany, A., Brugal, M. T., Molist, G., de La Fuente, L., & Bravo, M. J. (2014). Non-fatal opioid overdose and major depression among street-recruited young heroin users. European Addiction Research, 20(1), 1–7. https://doi.org/10.1159/000346787
  • Chitwood, D. D., Sanchez, J., Comerford, M., & McCoy, C. B. (2001). PRIMARY PREVENTIVE HEALTH CARE AMONG INJECTION DRUG USERS, OTHER SUSTAINED DRUG USERS, AND NON-USERS. Substance Use & Misuse, 36(6–7), 807–823. https://doi.org/10.1081/JA-100104092
  • Cochran, G., Gordon, A. J., Gellad, W. F., Chang, -C.-C. H., Lo-Ciganic, W.-H., Lobo, C., Cole, E., Frazier, W., Zheng, P., & Kelley, D. (2017). Medicaid prior authorization and opioid medication abuse and overdose. The American Journal of Managed Care, 23(5), e164.
  • Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D., Vlahov, D., & Galea, S. (2007). Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine, 14(7), 616–623. https://doi.org/10.1197/j.aem.2007.04.005
  • Colledge, S., Peacock, A., Leung, J., Larney, S., Grebely, J., Hickman, M., Cunningham, E., Trickey, A., Stone, J., & Vickerman, P. (2019). The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis. International Journal of Drug Policy, 73, 172–184. https://doi.org/10.1016/j.drugpo.2019.07.030
  • Darke, S., & Hall, W. (2003). Heroin overdose: Research and evidence-based intervention. Journal of Urban Health, 80(2), 189–200. https://doi.org/10.1093/jurban/jtg022
  • Darke, S., & Ross, J. (2001). The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia. Addiction, 96(10), 1443–1453. https://doi.org/10.1046/j.1360-0443.2001.961014438.x
  • Darke, S., Ross, J., Lynskey, M., & Teesson, M. (2004). Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence and risk factors. Drug and Alcohol Dependence, 73(1), 1–10. https://doi.org/10.1016/j.drugalcdep.2003.08.008
  • Darke, S., Williamson, A., Ross, J., Mills, K. L., Havard, A., & Teesson, M. (2007). Patterns of nonfatal heroin overdose over a 3-year period: Findings from the Australian treatment outcome study. Journal of Urban Health, 84(2), 283–291. https://doi.org/10.1007/s11524-006-9156-0
  • Darke, S., Williamson, A., Ross, J., & Teesson, M. (2005). Non‐fatal heroin overdose, treatment exposure and client characteristics: Findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24(5), 425–432. https://doi.org/10.1080/09595230500286005
  • Darke, S., & Zador, D. (1996). Fatal heroin ‘overdose’: A review. Addiction, 91(12), 1765–1772. https://doi.org/10.1046/j.1360-0443.1996.911217652.x
  • Dayton, L., Tobin, K., Falade-Nwulia, O., Davey-Rothwell, M., Al-Tayyib, A., Saleem, H., & Latkin, C. (2020). Racial disparities in overdose prevention among people who inject drugs. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 97(6), 823–830. https://doi.org/10.1007/s11524-020-00439-5
  • DeBeck, K., Cheng, T., Montaner, J. S., Beyrer, C., Elliott, R., Sherman, S., Wood, E., & Baral, S. (2017). HIV and the criminalisation of drug use among people who inject drugs: A systematic review. The Lancet HIV, 4(8), e357–e374. https://doi.org/10.1016/S2352-3018(17)30073-5
  • Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011). Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta‐analysis of cohort studies. Addiction, 106(1), 32–51. https://doi.org/10.1111/j.1360-0443.2010.03140.x
  • Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet, 379(9810), 55–70. https://doi.org/10.1016/S0140-6736(11)61138-0
  • Dilokthornsakul, P., Moore, G., Campbell, J. D., Lodge, R., Traugott, C., Zerzan, J., Allen, R., & Page, R. L., II. (2016). Risk factors of prescription opioid overdose among Colorado Medicaid beneficiaries. The Journal of Pain, 17(4), 436–443. https://doi.org/10.1016/j.jpain.2015.12.006
  • Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. Bmj, 315(7109), 629–634. https://doi.org/10.1136/bmj.315.7109.629
  • Escudero, D. J., Marshall, B. D., Kerr, T., Hayashi, K., Feng, C., Guillemi, S. A., Hogg, R. S., Montaner, J., Wood, E., & Milloy, M.-J. (2016). No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Addictive Behaviors, 60, 8–12. https://doi.org/10.1016/j.addbeh.2016.03.029
  • Fairgrieve, C., Nosova, E., Milloy, M., Fairbairn, N., DeBeck, K., Ahamad, K., Wood, E., Kerr, T., & Hayashi, K. (2020). Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting. Substance Abuse, 41(3), 323–330. https://doi.org/10.1080/08897077.2019.1677280
  • Farrell, M., Neeleman, J., Griffiths, P., & Strang, J. (1996). Suicide and overdose among opiate addicts. Addiction, 91(3), 321–323. https://doi.org/10.1111/j.1360-0443.1996.tb02282.x
  • Fendrich, M., Becker, J., & Hernandez-Meier, J. (2019). Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study. Addictive Behaviors Reports, 10, 100212. https://doi.org/10.1016/j.abrep.2019.100212
  • Finkelstein, Y., Macdonald, E. M., Hollands, S., Sivilotti, M. L., Hutson, J. R., Mamdani, M. M., Koren, G., Juurlink, D. N., Safety, C. D., & Network, E. R. (2016). Repetition of intentional drug overdose: A population-based study. Clinical Toxicology, 54(7), 585–589. https://doi.org/10.1080/15563650.2016.1177187
  • Fischer, B., Brissette, S., Brochu, S., Bruneau, J., El-Guebaly, N., Noël, L., Rehm, J., Tyndall, M., Wild, C., & Mun, P. (2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. Cmaj, 171(3), 235–239. https://doi.org/10.1503/cmaj.1031416
  • Geddes, L., Iversen, J., Darke, S., Dietze, P., & Maher, L. (2021). Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia. International Journal of Drug Policy, 96, 103245. https://doi.org/10.1016/j.drugpo.2021.103245
  • Ghiasvand, H., Bayani, A., Noroozi, A., Marshall, B. D., Koohestani, H. R., Hemmat, M., Mirzaee, M. S., Bayat, A. H., Noroozi, M., Ahounbar, E., & Armoon, B. (2018). Comparing injecting and sexual risk behaviors of long-term injectors with new injectors: A meta-analysis. Journal of Addictive Diseases, 37(3–4), 233–244. https://doi.org/10.1080/10550887.2019.1666622
  • Ghiasvand, H., Waye, K. M., Noroozi, M., Harouni, G. G., Armoon, B., & Bayani, A. (2019). Clinical determinants associated with quality of life for people who live with HIV/AIDS: A meta-analysis. BMC Health Services Research, 19(1), 768. https://doi.org/10.1186/s12913-019-4659-z
  • Glanz, J. M., Binswanger, I. A., Shetterly, S. M., Narwaney, K. J., & Xu, S. (2019). Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy. JAMA Network Open, 2(4), e192613–e192613. https://doi.org/10.1001/jamanetworkopen.2019.2613
  • Gossop, M., Stewart, D., Treacy, S., & Marsden, J. (2002). A prospective study of mortality among drug misusers during a 4‐year period after seeking treatment. Addiction, 97(1), 39–47. https://doi.org/10.1046/j.1360-0443.2002.00079.x
  • Groenewald, C. B., Zhou, C., Palermo, T. M., & Van Cleve, W. C. (2019). Associations between opioid prescribing patterns and overdose among privately insured adolescents. Pediatrics, 144(5), e20184070. https://doi.org/10.1542/peds.2018-4070
  • Grzebinski, S., Stein, L., & Dhamoon, M. S. (2021). Characteristics and outcomes of hospitalizations and readmissions for opioid dependence and overdose: Nationally representative data. Substance Abuse, 42(4), 654–661. https://doi.org/10.1080/08897077.2020.1823548
  • Hakansson, A., Schlyter, F., & Berglund, M. (2008). Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system. Drug and Alcohol Dependence, 94(1–3), 48–55. https://doi.org/10.1016/j.drugalcdep.2007.10.014
  • Heale, P., Dietze, P., & Fry, C. (2003). Intentional overdose among heroin overdose survivors. Journal of Urban Health, 80(2), 230–237. https://doi.org/10.1093/jurban/jtg026
  • Higgins, J. P., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions (Vol. 4). John Wiley & Sons.
  • Hoggatt, K. J., Frayne, S. M., Saechao, F. S., Yano, E. M., & Washington, D. L. (2019). Substance use disorder-related disparities in patient experiences of primary care. Health Equity, 3(1), 193–197. https://doi.org/10.1089/heq.2018.0069
  • Hulse, G., English, D., Milne, E., & Holman, C. (1999). The quantification of mortality resulting from the regular use of illicit opiates. Addiction, 94(2), 221–229. https://doi.org/10.1046/j.1360-0443.1999.9422216.x
  • Hunter, K., Park, J. N., Allen, S. T., Chaulk, P., Frost, T., Weir, B. W., & Sherman, S. G. (2018). Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. International Journal of Drug Policy, 57, 25–31. https://doi.org/10.1016/j.drugpo.2018.03.026
  • Kelty, E., & Hulse, G. (2017). Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone. International Journal of Drug Policy, 46, 54–60. https://doi.org/10.1016/j.drugpo.2017.05.039
  • Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence, 87(1), 39–45. https://doi.org/10.1016/j.drugalcdep.2006.07.009
  • Kerr, T., Mitra, S., Kennedy, M. C., & McNeil, R. (2017). Supervised injection facilities in Canada: Past, present, and future. Harm Reduction Journal, 14(1), 1–9. https://doi.org/10.1186/s12954-017-0154-1
  • Kim, K., Oh, H., Miller, D., Veloso, D., Lin, J., & McFarland, W. (2020). Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco. International Journal of Drug Policy, 102778. https://doi.org/10.1016/j.drugpo.2020.102778
  • Kimber, J., Dolan, K., van Beek, I., Hedrich, D., & Zurhold, H. (2003). Drug consumption facilities: An update since 2000. Drug and Alcohol Review, 22(2), 227–233. https://doi.org/10.1080/095952301000116951
  • Kinner, S. A., Milloy, M., Wood, E., Qi, J., Zhang, R., & Kerr, T. (2012). Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addictive Behaviors, 37(6), 691–696. https://doi.org/10.1016/j.addbeh.2012.01.019
  • Lake, S., Hayashi, K., Buxton, J., Milloy, M.-J., Dong, H., Wood, E., Montaner, J., & Kerr, T. (2015). The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug and Alcohol Dependence, 156, 297–303. https://doi.org/10.1016/j.drugalcdep.2015.09.026
  • Langabeer, J. R., Stotts, A. L., Bobrow, B. J., Wang, H. E., Chambers, K. A., Yatsco, A. J., Cardenas-Turanzas, M., & Champagne-Langabeer, T. (2021). Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug and Alcohol Dependence, 221, 108568. https://doi.org/10.1016/j.drugalcdep.2021.108568
  • Latkin, C. A., Edwards, C., Davey-Rothwell, M. A., Yang, C., & Tobin, K. E. (2018). The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland. Substance Abuse, 39(3), 384–389. https://doi.org/10.1080/08897077.2018.1439801
  • Lee, W. K., Hayashi, K., DeBeck, K., Milloy, M., Grant, C., Wood, E., & Kerr, T. (2020). Association between posttraumatic stress disorder and nonfatal drug overdose. Psychological Trauma: Theory, Research, Practice, and Policy, 12(4), 373. https://doi.org/10.1037/tra0000511
  • Martin, G., Vallance, K., Macdonald, S., Stockwell, T., Ivsins, A., Chow, C., Michelow, W., & Duff, C. (2014). Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users. Journal of Substance Use, 19(3), 239–244. https://doi.org/10.3109/14659891.2013.784369
  • Martins, S. S., Sampson, L., Cerdá, M., & Galea, S. (2015). Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature. American Journal of Public Health, 105(11), e29–e49. https://doi.org/10.2105/AJPH.2015.302843
  • Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., & Toufik, A. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet, 372(9651), 1733–1745. https://doi.org/10.1016/S0140-6736(08)61311-2
  • McAuliffe Staehler, T. M., & Palombi, L. C. (2020). Beneficial opioid management strategies: A review of the evidence for the use of opioid treatment agreements. Substance Abuse, 41(2), 208–215. https://doi.org/10.1080/08897077.2019.1692122
  • Mcgregor, C., Darke, S., Ali, R., & Christie, P. (1998). Experience of non‐fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions. Addiction, 93(5), 701–711. https://doi.org/10.1046/j.1360-0443.1998.9357016.x
  • Mehrpour, O., Karrari, P., & Afshari, R. (2012). Recreational use and overdose of ingested processed cannabis (Majoon Birjandi) in the eastern Iran. Human & Experimental Toxicology, 31(11), 1188–1189. https://doi.org/10.1177/0960327112446814
  • Milloy, M., Fairbairn, N., Hayashi, K., Suwannawong, P., Kaplan, K., Wood, E., & Kerr, T. (2010). Overdose experiences among injection drug users in Bangkok, Thailand. Harm Reduction Journal, 7(1), 1–7. https://doi.org/10.1186/1477-7517-7-9
  • Nam, Y. H., Bilker, W. B., DeMayo, F. J., Neuman, M. D., & Hennessy, S. (2020). Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: A cohort study. Pharmacoepidemiology and Drug Safety, 29(8), 931–938. https://doi.org/10.1002/pds.5067
  • Noroozi, M., Ahounbar, E., Eddin Karimi, S., Ahmadi, S., Najafi, M., Bazrafshan, A., Shushtari, Z. J., Farhadi, M. H., Higgs, P., & Rezaei, F. (2017). HIV risk perception and risky behavior among people who inject drugs in Kermanshah, Western Iran. International Journal of Behavioral Medicine, 24(4), 613–618. https://doi.org/10.1007/s12529-017-9634-7
  • Noroozi, M., Higgs, P., Bayani, A., Armoon, B., Astaneh, A. N., Moghaddam, L. F., & Askari, M. (2020). Non-fatal overdose among people who inject drugs in Tehran, Iran. Substance Abuse Treatment, Prevention, and Policy, 15(1), 1–7. https://doi.org/10.1186/s13011-020-00323-0
  • Noroozi, M., Marshall, B. D. L., Noroozi, A., & Armoon, B. (2018). Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach. Drug and Alcohol Review, 37(Suppl. 1), S303–S308. https://doi.org/10.1111/dar.12646
  • Noroozi, M., Noroozi, A., Sharifi, H., Harouni, G. G., Marshall, B. D., Ghisvand, H., Qorbani, M., & Armoon, B. (2019). Needle and syringe programs and HIV-related risk behaviors among men who inject drugs: A multilevel analysis of two cities in Iran. International Journal of Behavioral Medicine, 26(1), 50–58. https://doi.org/10.1007/s12529-018-9758-4
  • O’Halloran, C., Cullen, K., Njoroge, J., Jessop, L., Smith, J., Hope, V., & Ncube, F. (2017). The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. International Journal of Drug Policy, 46, 34–40. https://doi.org/10.1016/j.drugpo.2017.05.017
  • O’Keefe, D., Bowring, A., Aitken, C., & Dietze, P. (2018). The association between intentional overdose and same-sex sexual intercourse in a cohort of people who inject drugs in Melbourne, Australia. Substance Use & Misuse, 53(5), 755–762. https://doi.org/10.1080/10826084.2017.1363240
  • Ochoa, K. C., Hahn, J. A., Seal, K. H., & Moss, A. R. (2001). Overdosing among young injection drug users in San Francisco. Addictive Behaviors, 26(3), 453–460. https://doi.org/10.1016/S0306-4603(00)00115-5
  • Pavarin, R. M., Berardi, D., & Gambini, D. (2016). Emergency department presentation and mortality rate due to overdose: A retrospective cohort study on nonfatal overdoses. Substance Abuse, 37(4), 558–563. https://doi.org/10.1080/08897077.2016.1152342
  • Pizzicato, L. N., Johnson, C. C., & Viner, K. M. (2020). Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania. Substance Abuse, 41(3), 301–306. https://doi.org/10.1080/08897077.2019.1675115
  • Poschadel, S., Höger, R., Schnitzler, J., & Schreckenberg, D. (2002). Evaluation der Arbeit der Drogenkonsumräume in der Bundesrepublik Deutschland. Zeus GmbH, August.
  • Prangnell, A., Nosova, E., Milloy, M.-J., Wood, E., & Hayashi, K. (2019). The relationship between parental heavy drinking and non-fatal overdose among people who inject drugs in Vancouver, Canada. Addictive Behaviors, 89, 224–228. https://doi.org/10.1016/j.addbeh.2018.08.016
  • Rafful, C., Orozco, R., Rangel, G., Davidson, P., Werb, D., Beletsky, L., & Strathdee, S. A. (2018). Increased non‐fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction, 113(6), 1056–1063. https://doi.org/10.1111/add.14159
  • Riggs, K. R., Hoge, A. E., DeRussy, A. J., Montgomery, A. E., Holmes, S. K., Austin, E. L., Pollio, D. E., Kim, Y.-I., Varley, A. L., & Gelberg, L. (2020). Prevalence of and risk factors associated with nonfatal overdose among veterans who have experienced homelessness. JAMA Network Open, 3(3), e201190–e201190. https://doi.org/10.1001/jamanetworkopen.2020.1190
  • Riley, E. D., Evans, J. L., Hahn, J. A., Briceno, A., Davidson, P. J., Lum, P. J., & Page, K. (2016). A longitudinal study of multiple drug use and overdose among young people who inject drugs. American Journal of Public Health, 106(5), 915–917. https://doi.org/10.2105/AJPH.2016.303084
  • Rowe, C., Santos, G.-M., Behar, E., & Coffin, P. O. (2016). Correlates of overdose risk perception among illicit opioid users. Drug and Alcohol Dependence, 159, 234–239. https://doi.org/10.1016/j.drugalcdep.2015.12.018
  • Saini, R., Rao, R., Parmar, A., Mishra, A. K., Ambekar, A., Agrawal, A., & Dhingra, N. (2020). Rates, knowledge and risk factors of non‐fatal opioid overdose among people who inject drugs in India: A community‐based study. Drug and Alcohol Review, 39(1), 93–97. https://doi.org/10.1111/dar.13016
  • Saleem, H. T., Likindikoki, S., Nonyane, B. A., Nkya, I. H., Zhang, L., Mbwambo, J., & Latkin, C. (2020). Correlates of non-fatal, opioid overdose among women who use opioids in Dar Es Salaam, Tanzania. Drug and Alcohol Dependence, 218, 108419. https://doi.org/10.1016/j.drugalcdep.2020.108419
  • Sánchez‐Carbonell, X., & Seus, L. (2000). Ten‐year survival analysis of a cohort of heroin addicts in Catalonia: The EMETYST project. Addiction, 95(6), 941–948. https://doi.org/10.1046/j.1360-0443.2000.95694110.x
  • Seal, K. H., Kral, A. H., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., & Edlin, B. R. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. American Journal of Public Health, 91(11), 1842–1846. https://doi.org/10.2105/AJPH.91.11.1842
  • Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. Bmj, 2(350), g7647. https://doi.org/10.1136/bmj.g7647
  • Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605. https://doi.org/10.1007/s10654-010-9491-z
  • Stein, M. D., Conti, M. T., Kenney, S., Anderson, B. J., Flori, J. N., Risi, M. M., & Bailey, G. L. (2017). Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder. Drug and Alcohol Dependence, 179, 325–329. https://doi.org/10.1016/j.drugalcdep.2017.07.007
  • Stewart, D., Gossop, M., & Marsden, J. (2002). Reductions in non-fatal overdose after drug misuse treatment: Results from the National Treatment Outcome Research Study (NTORS). Journal of Substance Abuse Treatment, 22(1), 1–9. https://doi.org/10.1016/S0740-5472(01)00206-9
  • Stoové, M. A., Dietze, P. M., & Jolley, D. (2009). Overdose deaths following previous non‐fatal heroin overdose: Record linkage of ambulance attendance and death registry data. Drug and Alcohol Review, 28(4), 347–352. https://doi.org/10.1111/j.1465-3362.2009.00057.x
  • Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. Jama, 283(15), 2008–2012. https://doi.org/10.1001/jama.283.15.2008
  • Suffoletto, B., & Zeigler, A. (2020). Risk and protective factors for repeated overdose after opioid overdose survival. Drug and Alcohol Dependence, 209, 107890. https://doi.org/10.1016/j.drugalcdep.2020.107890
  • Tobin, K. E., & Latkin, C. A. (2003). The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. Journal of Urban Health, 80(2), 220–229. https://doi.org/10.1093/jurban/jtg025
  • Uusküla, A., Raag, M., Vorobjov, S., Rüütel, K., Lyubimova, A., Levina, O. S., & Heimer, R. (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. BMC Public Health, 15(1), 1–9. https://doi.org/10.1186/s12889-015-2604-6
  • van Beek, I., Kimber, J., Dakin, A., & Gilmour, S. (2004). The Sydney medically supervised injecting centre: Reducing harm associated with heroin overdose. Critical Public Health, 14(4), 391–406. https://doi.org/10.1080/09581590400027528
  • Van Den Boom, W., del Mar Quiroga, M., Fetene, D. M., Agius, P. A., Higgs, P. G., Maher, L., Hickman, M., Stoové, M. A., & Dietze, P. M. (2021). The Melbourne safe injecting room attracted people most in need of its service. American Journal of Preventive Medicine, 61(2), 217–224. https://doi.org/10.1016/j.amepre.2021.02.018
  • Vlahov, D., Wang, C., Ompad, D., Fuller, C. M., Caceres, W., Ouellet, L., Kerndt, P., Des Jarlais, D. C., & Garfein, R. S. (2008). Mortality risk among recent-onset injection drug users in five US cities. Substance Use & Misuse, 43(3–4), 413–428. https://doi.org/10.1080/10826080701203013
  • Warner‐Smith, M., Darke, S., & Day, C. (2002). Morbidity associated with non‐fatal heroin overdose. Addiction, 97(8), 963–967. https://doi.org/10.1046/j.1360-0443.2002.00132.x
  • Warner‐Smith, M., Darke, S., Lynskey, M., & Hall, W. (2001). Heroin overdose: Causes and consequences. Addiction, 96(8), 1113–1125. https://doi.org/10.1046/j.1360-0443.2001.96811135.x
  • Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004). Association of alcohol and drug use disorders and completed suicide: An empirical review of cohort studies. Drug and Alcohol Dependence, 76, S11–S19. https://doi.org/10.1016/j.drugalcdep.2004.08.003
  • Wines, J. D., Jr, Saitz, R., Horton, N. J., Lloyd-Travaglini, C., & Samet, J. H. (2007). Overdose after detoxification: A prospective study. Drug and Alcohol Dependence, 89(2–3), 161–169. https://doi.org/10.1016/j.drugalcdep.2006.12.019
  • Winter, R. J., Stoove, M., Degenhardt, L., Hellard, M. E., Spelman, T., Jenkinson, R., McCarthy, D. R., & Kinner, S. (2015). Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. Drug and Alcohol Dependence, 153, 43–49. https://doi.org/10.1016/j.drugalcdep.2015.06.011
  • Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004). Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users. Harm Reduction Journal, 1(1), 1–5. https://doi.org/10.1186/1477-7517-1-9
  • Wood, E., Li, K., Palepu, A., Marsh, D. C., Schechter, M. T., Hogg, R. S., Montaner, G., S., J., & Kerr, T. (2005). Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. Substance Use & Misuse, 40(8), 1153–1167. https://doi.org/10.1081/JA-200042287
  • Yang, Z., Wilsey, B., Bohm, M., Weyrich, M., Roy, K., Ritley, D., Jones, C., & Melnikow, J. (2015). Defining risk of prescription opioid overdose: Pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid. The Journal of Pain, 16(5), 445–453. https://doi.org/10.1016/j.jpain.2015.01.475
  • Yule, A. M., Carrellas, N. W., DiSalvo, M., Lyons, R. M., McKowen, J. W., Nargiso, J. E., Bergman, B. G., Kelly, J. F., & Wilens, T. E. (2019). Risk factors for overdose in young people who received substance use disorder treatment. The American Journal on Addictions, 28(5), 382–389. https://doi.org/10.1111/ajad.12938
  • Yule, A. M., Carrellas, N. W., Fitzgerald, M., McKowen, J. W., Nargiso, J. E., Bergman, B. G., Kelly, J. F., & Wilens, T. E. (2018). Risk factors for overdose in treatment-seeking youth with substance use disorders. The Journal of Clinical Psychiatry, 79(3), 17m11678. https://doi.org/10.4088/JCP.17m11678
  • Zhou, Y., Luo, W., Cao, X., Zhang, B., & Wu, Z. (2016). Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan. Zhonghua Liu Xing Bing Xue Za Zhi= Zhonghua Liuxingbingxue Zazhi, 37(5), 648–652. https://doi.org/10.3760/cma.j.issn.0254-6450.2016.05.012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.